New call for patient and healthcare-professional representatives on European Medicines Agency committees
The European Commission has relaunched its call for expressions of interest from representatives of patient and healthcare-professional organisations who wish to sit on the Committee for Advanced Therapies (CAT) or the Pharmacovigilance Risk Assessment Committee (PRAC).
The call was first launched in September 2011. It has been launched again at the request of the European Parliament because the initial call led to a low number of expressions of interest. The new call aims to widen the choice of representatives.
All expressions of interest will be assessed by the European Commission. As for all members of the Agency's committees, the representatives will not be permitted to have any financial or other interests in the pharmaceutical industry that could affect their impartiality, and will be required to make an annual declaration of their interests. All applicants are also required to submit a completed declaration of interest form with their expression of interest.
Representatives of patient, consumer and healthcare-professional organisations play an important role in the Agency's work, forming members of its scientific committees and other groups, reviewing information on medicines produced by the Agency and responding to specific requests for assistance.
Full details of the roles and how to apply are available from the European Commission. The deadline for expressions of interest is 1 October 2012.
- European Commission: News and updates on pharmaceuticals
- Expressions of interest invited for membership of European Medicines Agency committees and Management Board (03/10/2011)
- Committee for Advanced Therapies
- Pharmacovigilance Risk Assessment Committee
- Patients and consumers
- Healthcare professionals
- Handling conflicts of interests